Abstract
De novo CD5+ diffuse large B-cell lymphomas (DLBCL) are a distinct subgroup of DLBCL with poor prognosis. However the role of rituximab-containing therapy and salvage stem cell transplantation in this patients' population remain to be defined. We retrospectively reviewed clinical features and outcomes of 102 patients with de novo CD5+ DLBCL treated with rituximab-containing therapy at nine different institutions. By Hans' criteria, 64 patients had activated B-cell (ABC) subtype, 24 germinal center B-cell (GCB) subtype, and 14 were not evaluated. No patients had a myc translocation. Eighty-three patients were treated with rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone (R-CHOP), 7 with rituximab, etoposide, cyclophosphamide, doxorubicin, vincristine, prednisone (R-EPOCH), and 6 with R-CHOP with methotrexate, 3 g/m(2) . The overall response rate to front-line therapy was 85%. The 3-year progression free survival (PFS) and overall survival (OS) for all patients were 40 and 65%, respectively. The 3-year PFS for ABC- and GCB-subtypes was 34 and 45%, respectively. The 3-year OS for ABC- and GCB-subtypes was 62 and 67%, respectively. The median time to second treatment failure was 3 months and 1 month for ABC- and GC...Continue Reading
References
Dec 7, 1995·The New England Journal of Medicine·T PhilipJ L Harousseau
Feb 17, 2000·Nature·A A AlizadehL M Staudt
Jan 25, 2002·Blood·Motoko YamaguchiShigeo Nakamura
Jan 25, 2002·The New England Journal of Medicine·Bertrand CoiffierChristian Gisselbrecht
Sep 25, 2003·Blood·Christine P HansWing C Chan
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Laurie H SehnJoseph M Connors
Jun 7, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Thomas M HabermannSandra J Horning
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Mar 16, 2007·Blood·James O Armitage
Jun 17, 2008·Haematologica·Motoko YamaguchiShigeo Nakamura
Jun 25, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·D EnnishiK Hatake
Sep 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Georg LenzLouis M Staudt
Aug 26, 2009·Blood·Kerry J SavageRandy D Gascoyne
Mar 17, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·N NiitsuM Hirano
Jul 28, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christian GisselbrechtNorbert Schmitz
Jan 5, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·K MiyazakiS Nakamura
Sep 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Catherine ThieblemontChristian Gisselbrecht
Sep 29, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie M Vose
May 23, 2013·American Journal of Hematology·Preetesh JainSusan O'Brien
Dec 17, 2014·Blood·Laurie H Sehn, Randy D Gascoyne
Mar 12, 2015·Oncotarget·Zijun Y Xu-MonetteKen H Young
Citations
Jan 1, 2017·European Journal of Haematology·Beenu ThakralShaoying Li
Jul 18, 2017·Expert Review of Hematology·Alice Di RoccoMaurizio Martelli
Apr 4, 2018·Cancer Biology & Therapy·Yaping ZhangHongming Huang
Oct 30, 2016·Expert Review of Hematology·Vincent Camus, Hervé Tilly
Nov 19, 2018·Cancer Medicine·Eri IshikawaYoshiki Hirooka
Jul 31, 2019·Hematological Oncology·Peiqi ZhaoHuilai Zhang
Oct 24, 2019·PloS One·Hee Young NaJi Eun Kim
Jul 9, 2020·Journal of Cutaneous Pathology·Antonio Subtil, Alejandro A Gru
Oct 28, 2019·Haematologica·Kana MiyazakiUNKNOWN CD5+ DLBCL Treatment Study Group
Nov 4, 2016·International Journal of Surgical Pathology·Alfonso Úbeda RomeroSocorro María Rodríguez Pinilla
Oct 19, 2017·Blood Research·Hyun-Young KimSun-Hee Kim
Jul 12, 2020·Leukemia·Jie ZhuYe-Xiong Li
Nov 27, 2019·Pathology Oncology Research : POR·Satoko OkaMasaharu Nohgawa
Dec 4, 2016·Hematology·Bertrand Coiffier, Clémentine Sarkozy
Jun 23, 2018·Current Treatment Options in Oncology·Thomas A Ollila, Adam J Olszewski
May 11, 2019·Hematology·Huifen TangXiaohui Chen
Oct 16, 2020·Haematologica·Kana MiyazakiMotoko Yamaguchi
Jul 22, 2021·Leukemia & Lymphoma·Urshila Durani, Stephen M Ansell
Nov 20, 2021·Journal of Cutaneous Pathology·Jack LeeAlejandro A Gru